Association between peripheral plasmablasts and postoperative exacerbation in patients with thymoma‐associated myasthenia gravis. Issue 2 (22nd January 2019)
- Record Type:
- Journal Article
- Title:
- Association between peripheral plasmablasts and postoperative exacerbation in patients with thymoma‐associated myasthenia gravis. Issue 2 (22nd January 2019)
- Main Title:
- Association between peripheral plasmablasts and postoperative exacerbation in patients with thymoma‐associated myasthenia gravis
- Authors:
- Izaki, Shoko
Tanaka, Satoru
Oji, Satoru
Kubota, Akihiro
Fukaura, Hikoaki
Nakayama, Mitsuo
Nomura, Kyoichi - Abstract:
- Abstract: Objective: Thymoma‐associated myasthenia gravis (TAMG) is a type of myasthenia gravis (MG) that has a higher likelihood of worsening in comparison with non‐TAMG, and MG symptoms often worsen after thymectomy. We measured peripheral T/B lymphocyte subsets before and after thymectomy in TAMG patients, and investigated the relationships with the occurrence of postoperative exacerbation of MG symptoms. Methods: Participants were 10 TAMG patients, 40 healthy controls and five other surgical control patients. Peripheral lymphocyte subsets were measured using FACS‐Canto flow cytometry before, and 1, 7, and 28 days after thymectomy in the TAMG, and before and 7 days after thymectomy in the other surgical control patients. Results: Natural killer cells modestly decreased, and plasmablasts increased significantly ( P = 0.005) after 7 days postoperatively in comparison with preoperative values. Conversely, no obvious changes were observed in plasmablasts or natural killer cells in T/B lymphocyte subsets. From evaluation of postoperative clinical course and plasmablasts, exacerbation of MG symptoms was observed between 2 and 3 weeks after thymectomy in five of 10 patients (50%) of TAMG. In these five patients, plasmablasts markedly increased after thymectomy in three patients, among whom two patients had originally shown high plasmablast levels before thymectomy. There were also two patients who exacerbated without changes in plasmablast levels. Conclusions: In patients withAbstract: Objective: Thymoma‐associated myasthenia gravis (TAMG) is a type of myasthenia gravis (MG) that has a higher likelihood of worsening in comparison with non‐TAMG, and MG symptoms often worsen after thymectomy. We measured peripheral T/B lymphocyte subsets before and after thymectomy in TAMG patients, and investigated the relationships with the occurrence of postoperative exacerbation of MG symptoms. Methods: Participants were 10 TAMG patients, 40 healthy controls and five other surgical control patients. Peripheral lymphocyte subsets were measured using FACS‐Canto flow cytometry before, and 1, 7, and 28 days after thymectomy in the TAMG, and before and 7 days after thymectomy in the other surgical control patients. Results: Natural killer cells modestly decreased, and plasmablasts increased significantly ( P = 0.005) after 7 days postoperatively in comparison with preoperative values. Conversely, no obvious changes were observed in plasmablasts or natural killer cells in T/B lymphocyte subsets. From evaluation of postoperative clinical course and plasmablasts, exacerbation of MG symptoms was observed between 2 and 3 weeks after thymectomy in five of 10 patients (50%) of TAMG. In these five patients, plasmablasts markedly increased after thymectomy in three patients, among whom two patients had originally shown high plasmablast levels before thymectomy. There were also two patients who exacerbated without changes in plasmablast levels. Conclusions: In patients with exacerbation of neurological symptoms after thymectomy for TAMG, the plasmablast levels were originally high and/or became high postoperatively. Thus, elevated plasmablast levels could potentially be predictive of postoperative exacerbation of MG. Abstract : In thymoma‐associated myasthenia gravis patients, plasmablasts increased significantly at 7 days after thymectomy, compared with before thymectomy. … (more)
- Is Part Of:
- Clinical & experimental neuroimmunology. Volume 10:Issue 2(2019)
- Journal:
- Clinical & experimental neuroimmunology
- Issue:
- Volume 10:Issue 2(2019)
- Issue Display:
- Volume 10, Issue 2 (2019)
- Year:
- 2019
- Volume:
- 10
- Issue:
- 2
- Issue Sort Value:
- 2019-0010-0002-0000
- Page Start:
- 110
- Page End:
- 117
- Publication Date:
- 2019-01-22
- Subjects:
- peripheral T/B lymphocyte subsets -- plasmablasts -- thymectomy -- thymoma‐associated myasthenia gravis (TAMG)
616.80479 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1759-1961 ↗ - DOI:
- 10.1111/cen3.12494 ↗
- Languages:
- English
- ISSNs:
- 1759-1961
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 10208.xml